<DOC>
	<DOCNO>NCT02186652</DOCNO>
	<brief_summary>Multicenter , comparative single-dose pharmacokinetic ( PK ) study</brief_summary>
	<brief_title>PK Study With Pantoprazole Obese Children Adolescents</brief_title>
	<detailed_description>Evaluate pharmacokinetics pantoprazole obese child adolescent gastroesophageal reflux disease ( GERD ) follow administration oral dose pantoprazole .</detailed_description>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<criteria>1 . Participant 6 17 ( inclusive ) year age time consent 2 . BMI ≥95th percentile 3 . Diagnosis GERD establish prior 7 day receipt study drug dose define 1 following : 1. clinical symptom consistent GERD determine investigator 2. diagnosis erosive esophagitis endoscopy 3. esophageal biopsy histopathology consistent reflux esophagitis 4. abnormal pHmetry consistent reflux esophagitis 5. test result consistent GERD 4 . Written inform consent parent legally authorize representative/guardian participant assent per local IRB recommendation ageappropriate consent assent requirement 1 . Use pantoprazole , lansoprazole , omeprazole , esomeprazole rabeprazole within 48 hour prior dose study drug 2 . Use fluoxetine , fluvoxamine , ketoconazole , ticlopidine , felbamate , topiramate , valproic acid , phenobarbital , carbamazepine , erythromycin , clarithromycin , grapefruit juice , verapamil , diltiazem , cimetidine , St. John 's Wort , rifampin , rifapentine within seven day prior dose study drug 3 . Consumption food midnight day baseline visit 4 . Symptomatic asthma 5 . Type I diabetes 6 . History adverse reaction PPI 7 . Impaired hepatic activity define follow : AST ≥150 IU/L , ALT ≥150 IU/L , total bilirubin ≥2.0 mg/dl , alkaline phosphatase ≥600 IU/L 8 . Serum creatinine ≥2.0 mg/dL 9 . For female childbearing potential , positive pregnancy test result 10 . Known infection hepatitis B , C , HIV 11 . Any condition , opinion principal investigator , make participation unadvised unsafe .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>obese</keyword>
	<keyword>child</keyword>
	<keyword>adolescent</keyword>
	<keyword>GERD</keyword>
	<keyword>pharmacokinetic</keyword>
</DOC>